Publications

Bylsma LC, Levin-Sparenberg E, Lowe K, Sangare L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (MCRC) patients: A systematic literature review and meta-analysis. Poster presented as part of a Spotlight Poster Session at the International Society for Pharmacoepidemiology, August 2019, Philadelphia, PA.

Bylsma LC, Dean R, Lowe K, Sangare L, Alexander D, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis. Poster presented at the International Society for Pharmacoepidemiology, August 2019, Philadelphia, PA.

Bylsma LC, Saldanha G, Gulbech Ording A, Darvalics B, Tang J, Tof Sorensen H, Fryzek J. Cohort study of high frequency basal cell carcinoma (BCC) patients in Denmark. Poster presented at National Organization for Rare Disorders (NORD) Summit, October 2019, Washington, D.C.

Fryzek J, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at the International Society for Pharmacoepidemiology, August 2019, Philadelphia, PA.

Bylsma LC, Levin-Sparenberg E, Lowe K, Sangare L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (MCRC) patients: A systematic literature review and meta-analysis. Poster presented as part of a Spotlight Poster Session at the International Society for Pharmacoepidemiology, August 2019, Philadelphia, PA.

Chamberlain AM, Cohen SS, Weston SA, Fox KM, Xiang P Killian JM Qian Y. 2019. Relation of cardiovascular events and deaths to low-density lipoprotein cholesterol level among statin-treated patients with atherosclerotic cardiovascular disease. Am J Cardiol (e-pub ahead of print).

Babik, I, Movva N, Cunha A, Lobo MA. 2019. Characterization of self-feeding and problem solving in children with arm movement impairments. Poster presented at the Society for Research in Child Development Biennial Conference, Baltimore, MD. March 2019.

Storm HM, Shepard J, Czerkies LM, Kineman B, Cohen SS, Reichert H, Carvalho R. 2019. 2’-Fucosyllactose is well tolerated in a 100% whey, partially hydrolyzed infant formula with Bifidobacterium lactis: A randomized controlled trial. Global Pediat Health 6:1–10. DOI: 10.1177/2333794X19833995.

Mavunda K, Jiang X, Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Pediatric Academic Societies, Baltimore, Maryland, April 27–30, 2019.

Su J, Bylsma LC, Jiang X, Morales Arias J, Jain N, Nordyke RJ. Healthcare resource utilization among commercially insured cold agglutinin disease patients in the United States. Poster presentation at International Society for Pharmacoeconomics and Outcomes Research, New Orleans, Louisiana, May 18–22, 2019.